ESPR,Esperion Therapeutics, Inc. | Healthcare

Healthcare

ESPR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Esperion Therapeutics, Inc.ESPR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol.

Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.

The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program.

Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Latest News >

Coinbase Global Insider Sold Shares Worth $5,458,750, According to a Recent SEC Filing

Mar 12, 2024

04:30 PM EDT, 03/12/2024 (MT Newswires) -- Lawrence J Brock, Chief People Officer, on March 08, 2024, sold 21,835 shares in Coinbase Global ( COIN ) for $5,458,750. Following the Form 4 filing with the SEC, Brock has control over a total of 13,556 shares of the company, with 13,556 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1679788/000167978824000039/xslF345X03/wk-form4_1710275332.xml Price: 247.57, Change: -8.57,...

Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing

Mar 12, 2024

04:27 PM EDT, 03/12/2024 (MT Newswires) -- Trent G Kamke, Senior Vice President, Operations, on March 08, 2024, sold 4,542 shares in Lemaitre Vascular ( LMAT ) for $309,684. Following the Form 4 filing with the SEC, Kamke has control over a total of 4,561 shares of the company, with 4,561 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1158895/000143774924007457/xslF345X03/rdgdoc.xml ...

Applovin Insider Sold Shares Worth $1,625,000, According to a Recent SEC Filing

Mar 12, 2024

04:26 PM EDT, 03/12/2024 (MT Newswires) -- Victoria Valenzuela, Chief Legal Officer and Corporate Secretary, on March 08, 2024, sold 25,000 shares in Applovin ( APP ) for $1,625,000. Following the Form 4 filing with the SEC, Valenzuela has control over a total of 521,560 shares of the company, with 521,560 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218024002596/xslF345X03/primarydocument.xml Price: 61.85, Change:...

Applovin Insider Sold Shares Worth $809,268, According to a Recent SEC Filing

Mar 12, 2024

04:26 PM EDT, 03/12/2024 (MT Newswires) -- Katie Kihorany Jansen, Chief Marketing Officer, on March 08, 2024, sold 12,650 shares in Applovin ( APP ) for $809,268. Following the Form 4 filing with the SEC, Jansen has control over a total of 1,418,354 shares of the company, with 1,264,284 shares held directly and 154,070 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1751008/000156218024002597/xslF345X03/primarydocument.xml Price:...